Currently, there are 1.81B common shares owned by the public and among those 1.24B shares have been available to trade.
Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, accounting for 0 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling 0 shares.
The company’s stock has a 5-day price change of -3.33% and -5.55% over the past three months. CPNG shares are trading 8.33% year to date (YTD), with the 12-month market performance up to 30.54% higher. It has a 12-month low price of $17.34 and touched a high of $26.91 over the same period. CPNG has an average intraday trading volume of 7.93 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -2.09%, 2.45%, and 2.78% respectively.
Institutional ownership of Coupang Inc (NYSE: CPNG) shares accounts for 52.45% of the company’s 1.81B shares outstanding.
It has a market capitalization of $42.99B and a beta (3y monthly) value of 1.10. The stock’s trailing 12-month PE ratio is 287.21, while the earnings-per-share (ttm) stands at $0.08. The company has a PEG of 2.23 and a Quick Ratio of 0.89 with the debt-to-equity ratio at 0.91. Price movements for the stock have been influenced by the stock’s volatility, which stands at 5.06% over the week and 3.17% over the month.
Earnings per share for the fiscal year are expected to increase by 346.46%, and 112.90% over the next financial year.
Looking at the support for the CPNG, a number of firms have released research notes about the stock. Deutsche Bank stated their Buy rating for the stock in a research note on February 26, 2025, with the firm’s price target at $28.50. Bernstein coverage for the Coupang Inc (CPNG) stock in a research note released on October 07, 2024 offered a Outperform rating with a price target of $30. CLSA was of a view on September 04, 2024 that the stock is Outperform, while UBS gave the stock Buy rating on May 16, 2024, issuing a price target of $26. BofA Securities on their part issued Buy rating on May 03, 2024.
